These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7875896)

  • 21. [2 cases of malarial flare-up with fatal outcome inspite of treatment with halofantrine].
    Angel G; Diatta B; Seck M; Aulagnier V; Seignot P
    Presse Med; 1996 Nov; 25(33):1604. PubMed ID: 8975237
    [No Abstract]   [Full Text] [Related]  

  • 22. A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children.
    Anabwani GM; Esamai FO; Menya DA
    East Afr Med J; 1996 Mar; 73(3):155-8. PubMed ID: 8698011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short report: in vivo sensitivity of Plasmodium falciparum to halofantrine in southern central Vietnam.
    Doan HN; Taylor WR; Nguyen DT; Tran TU; Fryauff DJ; Susanti I; Gómez-Saladín E; Le DC; Baird JK
    Am J Trop Med Hyg; 2003 Nov; 69(5):553-4. PubMed ID: 14695095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Halofantrine in G-6 PD deficiency.
    Handa R; Wig N; Aggarwal P; Suresh V; Biswas A; Wali JP
    J Assoc Physicians India; 1997 Nov; 45(11):899. PubMed ID: 11229205
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of dual chloroquine and halofantrine treatment failure in Zimbabwe.
    Mharakurwa S
    Cent Afr J Med; 1995 Oct; 41(10):327-9. PubMed ID: 8556780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical trial with halofantrine on patients with falciparum malaria in Colombia.
    Restrepo M; Botero D; Marquez RE; Boudreau EF; Navaratnam V
    Bull World Health Organ; 1996; 74(6):591-7. PubMed ID: 9060219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correct usage of amino alcohols].
    Touze JE
    Med Trop (Mars); 1995; 55(3 Suppl):24-5. PubMed ID: 8609819
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mislead by 'malaria medication in one's pocket'].
    Lampe AS; Bakker RB; Smith SJ
    Ned Tijdschr Geneeskd; 1993 Aug; 137(33):1674. PubMed ID: 8371800
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trial of halofantrine with modified doses for treatment of malaria in the hospital for tropical diseases.
    Krudsood S; Singhasivanon P; Silachamroon U; Treeprasertsuk S; Kaivipakbanyai W; Chalermrut K; Phophak N; Horton J; Kyle D; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):255-61. PubMed ID: 11556573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Halofantrine--an alternative treatment for malaria.
    Drug Ther Bull; 1993 Jul; 31(15):59-60. PubMed ID: 8375274
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cardiac rhythm disturbances and prolonged QT interval with halofantrine].
    Lavallée I; Marc E; Moulin F; Treluyer JM; Imbert P; Gendrel D
    Arch Pediatr; 2001 Aug; 8(8):795-800. PubMed ID: 11524908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of halofantrine in healthy Thai volunteers.
    Karbwang J; Ward SA; Milton KA; Na Bangchang K; Edwards G
    Br J Clin Pharmacol; 1991 Nov; 32(5):639-40. PubMed ID: 1954081
    [No Abstract]   [Full Text] [Related]  

  • 33. Cerebral malaria in children: therapeutic considerations.
    Thapa BR; Marwaha RK; Kumar L; Mehta S
    Indian Pediatr; 1988 Jan; 25(1):61-5. PubMed ID: 3220527
    [No Abstract]   [Full Text] [Related]  

  • 34. [Eight-year surveillance of imported malaria in YongKang city].
    Zhou Z; Xu F; Chen S
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):266. PubMed ID: 12563851
    [No Abstract]   [Full Text] [Related]  

  • 35. Halofantrine to prevent falciparum malaria on return from malarious areas.
    Baudon D; Bernard J; Moulia-Pelat JP; Martet G; Sarrouy J; Touze JE; Spiegel A; Lantrade P; Picq JJ
    Lancet; 1990 Aug; 336(8711):377. PubMed ID: 1975358
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long circulating nanocapsules: interest in the treatment of severe malaria with halofantrine].
    Legrand P; Mosqueira V; Loiseau P; Bories C; Barratt G
    Ann Pharm Fr; 2003 May; 61(3):196-202. PubMed ID: 12714932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients.
    Gimenez F; Gillotin C; Basco LK; Bouchaud O; Aubry AF; Wainer IW; Le Bras J; Farinotti R
    Eur J Clin Pharmacol; 1994; 46(6):561-2. PubMed ID: 7995326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recrudescence of falciparum malaria following treatment with halofantrine.
    Kano S; Masuda G; Suzuki M
    Kansenshogaku Zasshi; 1994 Apr; 68(4):536-8. PubMed ID: 8027602
    [No Abstract]   [Full Text] [Related]  

  • 39. [Malaria--state of the art. 2: Therapy and prevention of malaria].
    Backmund M; von Zielonka M; Hartmann WJ; Hesse J; Eichenlaub D
    Fortschr Med; 1999 Jan; 117(1-2):24-8. PubMed ID: 10036807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of Plasmodium falciparum isolates to halofantrine in the Central Province of Papua New Guinea.
    Hombhanje FW; Kereu RK
    P N G Med J; 1998 Mar; 41(1):30-6. PubMed ID: 10741175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.